Research Article
Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus
Figure 3
Effects of HMS5552 on oral drug tolerance 1 (a) and 27 days (b) after treatment with HMS5552. HMS-L group, low-dose (10 mg/kg) HMS5552-treated diabetic group; HMS-H group, high-dose (30 mg/kg) HMS5552-treated diabetic group. The data are expressed as the mean ± SD (). , compared with the diabetic group.
(a) |
(b) |